Christopher Ryan - GEO Ex HR
| GEG Stock | EUR 27.42 0.08 0.29% |
Insider
Christopher Ryan is Ex HR of The GEO Group
| Phone | 561 893 0101 |
| Web | https://www.geogroup.com |
Christopher Ryan Latest Insider Activity
Tracking and analyzing the buying and selling activities of Christopher Ryan against GEO stock is an integral part of due diligence when investing in GEO. Christopher Ryan insider activity provides valuable insight into whether GEO is net buyers or sellers over its current business cycle. Note, GEO insiders must abide by specific rules, including filing SEC forms every time they buy or sell GEO'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Christopher Ryan 2 days ago Disposition of tradable shares by Christopher Ryan of Geo subject to Rule 16b-3 | ||
Christopher Ryan over a month ago Disposition of 46608 shares by Christopher Ryan of Gevo at 0.5059 subject to Rule 16b-3 | ||
Christopher Ryan over a year ago Sale by Christopher Ryan of 13776 shares of Lakeland Industries | ||
Christopher Ryan over a year ago Acquisition by Christopher Ryan of 7802 shares of Lakeland Industries subject to Rule 16b-3 |
GEO Management Efficiency
The company has return on total asset (ROA) of 0.0577 % which means that it generated a profit of $0.0577 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1605 %, meaning that it generated $0.1605 on every $100 dollars invested by stockholders. GEO's management efficiency ratios could be used to measure how well GEO manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Timothy McHugh | Welltower | 38 | |
| Eric Mendelsohn | National Health Investors | 61 | |
| Kevin Pascoe | National Health Investors | 42 | |
| Tracey Dexter | Sabra Health Care | 49 | |
| Rosa Hooper | Medical Properties Trust | N/A | |
| Jeffrey Bray | Sabra Health Care | N/A | |
| Colleen Schaller | National Health Investors | N/A | |
| Charles Shaffer | Sabra Health Care | 49 | |
| Lukas CFA | Sabra Health Care | N/A | |
| Peter Nyland | Sabra Health Care | N/A | |
| Talya NevoHacohen | Sabra Health Care | 62 | |
| Eliza Gozar | Sabra Health Care | N/A | |
| James Hanna | Medical Properties Trust | 50 | |
| Joseph Forlenza | Sabra Health Care | 61 | |
| David Travis | National Health Investors | 48 | |
| Michael Costa | Sabra Health Care | 43 | |
| Kimberly Ouimet | National Health Investors | N/A | |
| Mary JD | Welltower | N/A | |
| Harold Andrews | Sabra Health Care | 58 | |
| Krishna Soma | Welltower | N/A | |
| Dana Hambly | National Health Investors | N/A | |
Management Performance
| Return On Equity | 0.16 | |||
| Return On Asset | 0.0577 |
GEO Group Leadership Team
Elected by the shareholders, the GEO's board of directors comprises two types of representatives: GEO inside directors who are chosen from within the company, and outside directors, selected externally and held independent of GEO. The board's role is to monitor GEO's management team and ensure that shareholders' interests are well served. GEO's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, GEO's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ann Schlarb, VP Care | ||
| Daniel Ragsdale, Ex Compliance | ||
| Brian Evans, VP CFO | ||
| Jose Rosario, Chief VP | ||
| Christopher Ryan, Ex HR | ||
| George Zoley, Founder Chairman | ||
| Jose JD, CEO Director | ||
| Ronald Brack, Chief VP | ||
| Daniel Friend, VP Fin | ||
| Joe Negron, Gen Sec |
GEO Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is GEO a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.16 | |||
| Return On Asset | 0.0577 | |||
| Profit Margin | 0.07 % | |||
| Operating Margin | 0.16 % | |||
| Current Valuation | 3.21 B | |||
| Shares Outstanding | 124.15 M | |||
| Shares Owned By Insiders | 4.80 % | |||
| Shares Owned By Institutions | 82.86 % | |||
| Price To Earning | 12.24 X | |||
| Price To Book | 1.21 X |
Currently Active Assets on Macroaxis
Other Information on Investing in GEO Stock
GEO financial ratios help investors to determine whether GEO Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in GEO with respect to the benefits of owning GEO security.